Accelerate Diagnostics, Inc.

NasdaqCM:AXDX Stock Report

Market Cap: US$27.9m

Accelerate Diagnostics Management

Management criteria checks 2/4

Accelerate Diagnostics' CEO is Jack Phillips, appointed in Feb 2020, has a tenure of 4.92 years. total yearly compensation is $3.00M, comprised of 19.8% salary and 80.2% bonuses, including company stock and options. directly owns 0.65% of the company’s shares, worth $181.66K. The average tenure of the management team and the board of directors is 2.3 years and 4.7 years respectively.

Key information

Jack Phillips

Chief executive officer

US$3.0m

Total compensation

CEO salary percentage19.8%
CEO tenure4.9yrs
CEO ownership0.7%
Management average tenure2.3yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

Market Participants Recognise Accelerate Diagnostics, Inc.'s (NASDAQ:AXDX) Revenues Pushing Shares 38% Higher

Apr 17
Market Participants Recognise Accelerate Diagnostics, Inc.'s (NASDAQ:AXDX) Revenues Pushing Shares 38% Higher

Accelerate Diagnostics spikes as Chief Technology Officer raises stake

Aug 30

Need To Know: Analysts Are Much More Bullish On Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

Aug 20
Need To Know: Analysts Are Much More Bullish On Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

Accelerate Diagnostics jumps 14% after beating Q2 estimates

Aug 15

Need To Know: The Consensus Just Cut Its Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Estimates For 2022

Mar 15
Need To Know: The Consensus Just Cut Its Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Estimates For 2022

Accelerate Diagnostics And T2 Biosystems: Financial Woes Set To Continue In 2022

Jan 04

Accelerate Diagnostics: An Investment Assessment

Sep 07

Should You Take Comfort From Insider Transactions At Accelerate Diagnostics, Inc. (NASDAQ:AXDX)?

Feb 20
Should You Take Comfort From Insider Transactions At Accelerate Diagnostics, Inc. (NASDAQ:AXDX)?

Accelerate Diagnostics foresees Q4 and FY2020 revenue below consensus

Jan 12

Reflecting on Accelerate Diagnostics' (NASDAQ:AXDX) Share Price Returns Over The Last Three Years

Dec 29
Reflecting on Accelerate Diagnostics' (NASDAQ:AXDX) Share Price Returns Over The Last Three Years

CEO Compensation Analysis

How has Jack Phillips's remuneration changed compared to Accelerate Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$53m

Jun 30 2024n/an/a

-US$38m

Mar 31 2024n/an/a

-US$59m

Dec 31 2023US$3mUS$595k

-US$62m

Sep 30 2023n/an/a

-US$63m

Jun 30 2023n/an/a

-US$80m

Mar 31 2023n/an/a

-US$66m

Dec 31 2022US$2mUS$595k

-US$62m

Sep 30 2022n/an/a

-US$71m

Jun 30 2022n/an/a

-US$64m

Mar 31 2022n/an/a

-US$67m

Dec 31 2021US$3mUS$595k

-US$78m

Sep 30 2021n/an/a

-US$74m

Jun 30 2021n/an/a

-US$84m

Mar 31 2021n/an/a

-US$81m

Dec 31 2020US$4mUS$555k

-US$78m

Sep 30 2020n/an/a

-US$81m

Jun 30 2020n/an/a

-US$82m

Mar 31 2020n/an/a

-US$84m

Dec 31 2019US$12mUS$162k

-US$84m

Compensation vs Market: Jack's total compensation ($USD3.00M) is above average for companies of similar size in the US market ($USD645.47K).

Compensation vs Earnings: Jack's compensation has increased whilst the company is unprofitable.

CEO

Jack Phillips (58 yo)

4.9yrs

Tenure

US$3,004,105

Compensation

Mr. Jack Phillips has been Chief Executive Officer, President and Director of Accelerate Diagnostics, Inc. since February 1, 2020. Mr. Phillips served as Chief Operating Officer of Accelerate Diagnostics,...

Leadership Team

NamePositionTenureCompensationOwnership
Jack Phillips
CEO, President & Director4.9yrsUS$3.00m0.65%
$ 181.7k
David Patience
Chief Financial Officer1.8yrsUS$1.16m0.20%
$ 57.1k
Lawrence Mertz
Chief Technology Officer2.6yrsUS$952.16k0.33%
$ 91.5k
Maya Gowri
Senior VP & Head of Operations2yrsno datano data
Laura Pierson
Investor Relations Officerno datano datano data
John Meduri
Chief Strategy Officer8.8yrsno datano data
Chris Thode
Senior Vice President of US Commercial2yrsno datano data

2.3yrs

Average Tenure

58yo

Average Age

Experienced Management: AXDX's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jack Phillips
CEO, President & Director4.9yrsUS$3.00m0.65%
$ 181.7k
John Patience
Independent Director12.6yrsUS$231.32k3.48%
$ 971.4k
Jack Schuler
Independent Director12.6yrsUS$231.32k33.26%
$ 9.3m
Hany Massarany
Independent Chairman of the Board4.7yrsUS$231.32k0.16%
$ 44.5k
Louise Francesconi
Independent Director5.1yrsUS$231.32k0.13%
$ 37.4k
Marran J. Ogilvie
Independent Director1.7yrsUS$233.68kno data
Marin Kollef
Scientific Advisory Board Memberno datano datano data
Connie Price
Scientific Advisory Board Memberno datano datano data
Mark Black
Independent Director1.7yrsUS$233.68kno data
Richard Wunderink
Scientific Advisory Board Memberno datano datano data
Wayne Burris
Independent Director2.9yrsUS$231.32k0.0067%
$ 1.9k
Jenny Regan
Independent Director1.7yrsUS$233.68k0.050%
$ 14.1k

4.7yrs

Average Tenure

65yo

Average Age

Experienced Board: AXDX's board of directors are considered experienced (4.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 03:49
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Accelerate Diagnostics, Inc. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sean LavinBTIG
Garrett NelsonCFRA Equity Research
Alexander NowakCraig-Hallum Capital Group LLC